2.50
Hdl Handle:
http://hdl.handle.net/10755/154988
Type:
Presentation
Title:
Importance of Prognostic and Functional Classification of Heart Failure
Abstract:
Importance of Prognostic and Functional Classification of Heart Failure
Conference Sponsor:Sigma Theta Tau International
Conference Year:2010
Author:Athilingam, Ponrathi R., PhD, RN, ACNP
P.I. Institution Name:University of Rochester
Title:Assistant Professor Clinical Nursing
21st INRC [Evidence-Based Practice Presentation] Heart failure (HF) is a group of signs and symptoms caused by many disease processes that have weakened the heart over time. Although, HF course may be improved with modern therapies, it involves gradual deterioration with interrupted bouts of severe decompensation and ultimately death. The American Heart Association (AHA)/American College of Cardiology (ACC) staging highlight the importance of known risk factors and structural abnormalities of the heart in the development of HF. It reinforces the concept that HF is a progressive disease whose onset can be prevented, or its progression halted by early identification and intervention. The New York Heart Association (NYHA) functional classification relates to symptoms of everyday activities and the patient's quality of life. Symptoms are graded at four levels based on how much they limit functional capacity. Unlike the AHA/ACC staging system, the NYHA class often can shift from one level to another as functional capacity improves or worsens. Table data: Title, Table Comparing AHA/ACC stage and NYHA Classification; Headings: HF Stage, Structural Damage to Heart, NYHA Classification, Physical activity. A: High risk, no damage, Class I, No limitation. B: Damage, no or mild symptoms, Class II, Slight limitation. C: Damage amenable to treatment, Class III, Marked limitation. D: Damage, refractory to conventional treatment, Class IV, Unable to carry out any activity without discomfort. Typical stage D patients include those who require frequent hospital admissions for HF, awaiting a heart transplant, supported with intravenous inotropes or mechanical assist devices, and are receiving hospice care for end-stage HFEvidence suggests knowledge of assessing the AHA/ACC stages helps to prevent and manage HF in those at risk and complements NYHA classification system, which gauges the severity of symptoms in people who are at AHA/ACC stage C and D that augments timely dialogue regarding end life issues with end stage HF patients.
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleImportance of Prognostic and Functional Classification of Heart Failureen_GB
dc.identifier.urihttp://hdl.handle.net/10755/154988-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Importance of Prognostic and Functional Classification of Heart Failure</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2010</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Athilingam, Ponrathi R., PhD, RN, ACNP</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">University of Rochester</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Assistant Professor Clinical Nursing</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">ponrathi_athilingam@urmc.rochester.edu</td></tr><tr><td colspan="2" class="item-abstract">21st INRC [Evidence-Based Practice Presentation] Heart failure (HF) is a group of signs and symptoms caused by many disease processes that have weakened the heart over time. Although, HF course may be improved with modern therapies, it involves gradual deterioration with interrupted bouts of severe decompensation and ultimately death. The American Heart Association (AHA)/American College of Cardiology (ACC) staging highlight the importance of known risk factors and structural abnormalities of the heart in the development of HF. It reinforces the concept that HF is a progressive disease whose onset can be prevented, or its progression halted by early identification and intervention. The New York Heart Association (NYHA) functional classification relates to symptoms of everyday activities and the patient's quality of life. Symptoms are graded at four levels based on how much they limit functional capacity. Unlike the AHA/ACC staging system, the NYHA class often can shift from one level to another as functional capacity improves or worsens. Table data: Title, Table Comparing AHA/ACC stage and NYHA Classification; Headings: HF Stage, Structural Damage to Heart, NYHA Classification, Physical activity. A: High risk, no damage, Class I, No limitation. B: Damage, no or mild symptoms, Class II, Slight limitation. C: Damage amenable to treatment, Class III, Marked limitation. D: Damage, refractory to conventional treatment, Class IV, Unable to carry out any activity without discomfort. Typical stage D patients include those who require frequent hospital admissions for HF, awaiting a heart transplant, supported with intravenous inotropes or mechanical assist devices, and are receiving hospice care for end-stage HFEvidence suggests knowledge of assessing the AHA/ACC stages helps to prevent and manage HF in those at risk and complements NYHA classification system, which gauges the severity of symptoms in people who are at AHA/ACC stage C and D that augments timely dialogue regarding end life issues with end stage HF patients.</td></tr></table>en_GB
dc.date.available2011-10-26T13:26:32Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T13:26:32Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.